Shenyang Xingqi Pharmaceutical Co.,Ltd (300573.SZ)
CNY 77.66
(-1.03%)
CNY 77.66
(-1.03%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 276.51 Million CNY | 3.31% |
| 2022 | 250.1 Million CNY | 0.69% |
| 2021 | 248.39 Million CNY | 134.92% |
| 2020 | 105.73 Million CNY | 180.56% |
| 2019 | 37.68 Million CNY | 227.02% |
| 2018 | 11.52 Million CNY | -75.03% |
| 2017 | 46.14 Million CNY | -13.73% |
| 2016 | 53.49 Million CNY | 147.89% |
| 2015 | 21.57 Million CNY | 19.42% |
| 2014 | 18.06 Million CNY | -65.22% |
| 2013 | 51.94 Million CNY | 3.9% |
| 2012 | 50 Million CNY | 22.19% |
| 2011 | 40.92 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 38.37 Million CNY | -32.81% |
| 2024 Q2 | 152.71 Million CNY | 297.92% |
| 2024 Q3 | 134.32 Million CNY | -12.04% |
| 2023 Q2 | 78.41 Million CNY | 242.92% |
| 2023 Q1 | 22.86 Million CNY | 1017.81% |
| 2023 FY | 258.37 Million CNY | 3.31% |
| 2023 Q3 | 110.53 Million CNY | 40.96% |
| 2023 Q4 | 57.11 Million CNY | -48.32% |
| 2022 FY | 250.1 Million CNY | 0.69% |
| 2022 Q2 | 65.24 Million CNY | -25.83% |
| 2022 Q1 | 87.95 Million CNY | 81.59% |
| 2022 Q4 | -2.49 Million CNY | -102.51% |
| 2022 Q3 | 99.39 Million CNY | 52.34% |
| 2021 FY | 248.39 Million CNY | 134.92% |
| 2021 Q2 | 60.91 Million CNY | 46.05% |
| 2021 Q3 | 97.32 Million CNY | 59.76% |
| 2021 Q4 | 48.43 Million CNY | -50.23% |
| 2021 Q1 | 41.71 Million CNY | 0.43% |
| 2020 Q4 | 41.53 Million CNY | -12.9% |
| 2020 Q3 | 47.68 Million CNY | 77.73% |
| 2020 FY | 105.73 Million CNY | 180.56% |
| 2020 Q2 | 26.83 Million CNY | 360.16% |
| 2020 Q1 | -10.31 Million CNY | -262.3% |
| 2019 Q4 | 6.35 Million CNY | -75.25% |
| 2019 Q2 | 4.41 Million CNY | 253.24% |
| 2019 Q1 | 1.24 Million CNY | 284.87% |
| 2019 FY | 37.68 Million CNY | 227.02% |
| 2019 Q3 | 25.66 Million CNY | 481.47% |
| 2018 Q3 | 15.9 Million CNY | 2772.82% |
| 2018 FY | 11.52 Million CNY | -75.03% |
| 2018 Q4 | -676.02 Thousand CNY | -104.25% |
| 2018 Q2 | -595.01 Thousand CNY | 80.86% |
| 2018 Q1 | -3.1 Million CNY | 8.55% |
| 2017 FY | 46.14 Million CNY | -13.73% |
| 2017 Q4 | -3.39 Million CNY | -121.57% |
| 2017 Q2 | 24.38 Million CNY | 159.15% |
| 2017 Q1 | 9.4 Million CNY | 23.83% |
| 2017 Q3 | 15.75 Million CNY | -35.38% |
| 2016 FY | 53.49 Million CNY | 147.89% |
| 2016 Q1 | 8.54 Million CNY | 0.0% |
| 2016 Q2 | 22.25 Million CNY | 160.59% |
| 2016 Q3 | 15.09 Million CNY | -32.2% |
| 2016 Q4 | 7.59 Million CNY | -49.66% |
| 2015 FY | 21.57 Million CNY | 19.42% |
| 2014 FY | 18.06 Million CNY | -65.22% |
| 2014 Q4 | -5.45 Million CNY | 0.0% |
| 2013 FY | 51.94 Million CNY | 3.9% |
| 2012 FY | 50 Million CNY | 22.19% |
| 2011 FY | 40.92 Million CNY | 0.0% |